TR200000764T2 - Fosfolamban inhibitörleri olarak, 1-okza, aza ve tiyanaftalin-2-on'ların biseterleri. - Google Patents
Fosfolamban inhibitörleri olarak, 1-okza, aza ve tiyanaftalin-2-on'ların biseterleri.Info
- Publication number
- TR200000764T2 TR200000764T2 TR2000/00764T TR200000764T TR200000764T2 TR 200000764 T2 TR200000764 T2 TR 200000764T2 TR 2000/00764 T TR2000/00764 T TR 2000/00764T TR 200000764 T TR200000764 T TR 200000764T TR 200000764 T2 TR200000764 T2 TR 200000764T2
- Authority
- TR
- Turkey
- Prior art keywords
- alkyl
- arylalkyl
- aryl
- hydrogen
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US10411498A | 1998-06-25 | 1998-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200000764T2 true TR200000764T2 (tr) | 2001-03-21 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/00764T TR200000764T2 (tr) | 1997-09-24 | 1998-09-24 | Fosfolamban inhibitörleri olarak, 1-okza, aza ve tiyanaftalin-2-on'ların biseterleri. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (xx) |
| JP (1) | JP2003525838A (xx) |
| KR (1) | KR20010015607A (xx) |
| CN (1) | CN1143857C (xx) |
| AU (1) | AU735729B2 (xx) |
| BR (1) | BR9813216A (xx) |
| CA (1) | CA2304849A1 (xx) |
| EA (1) | EA003084B1 (xx) |
| EE (1) | EE04494B1 (xx) |
| HU (1) | HUP0003647A3 (xx) |
| ID (1) | ID24373A (xx) |
| IL (1) | IL134662A0 (xx) |
| NO (1) | NO20001569L (xx) |
| NZ (1) | NZ503044A (xx) |
| PL (1) | PL339493A1 (xx) |
| SK (1) | SK3902000A3 (xx) |
| TR (1) | TR200000764T2 (xx) |
| WO (1) | WO1999015523A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026491B2 (en) | 2000-07-21 | 2006-04-11 | Chugai Seiyaku Kabushiki Kaisha | Coumarin derivatives useful as TNFα inhibitors |
| AU2002226634B2 (en) * | 2001-03-30 | 2007-01-25 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (fr) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (de) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| DK391189A (da) * | 1988-08-10 | 1990-02-11 | Otsuka Pharma Co Ltd | Carbostyrilderivater |
| CA2022236A1 (en) * | 1989-07-31 | 1991-02-01 | Hiroaki Yanagisawa | Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders |
| DE4337906A1 (de) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Verwendung von Cumarinderivaten |
-
1998
- 1998-09-24 ID IDW20000564A patent/ID24373A/id unknown
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 CA CA002304849A patent/CA2304849A1/en not_active Abandoned
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/xx unknown
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/ko not_active Application Discontinuation
- 1998-09-24 PL PL98339493A patent/PL339493A1/xx unknown
- 1998-09-24 EE EEP200000179A patent/EE04494B1/xx not_active IP Right Cessation
- 1998-09-24 EA EA200000352A patent/EA003084B1/ru not_active IP Right Cessation
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/hu unknown
- 1998-09-24 EP EP98946482A patent/EP1017691A1/en not_active Withdrawn
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/ja active Pending
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/zh not_active Expired - Fee Related
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/sk unknown
- 1998-09-24 IL IL13466298A patent/IL134662A0/xx unknown
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/pt not_active IP Right Cessation
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/en not_active Application Discontinuation
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813216A (pt) | 2000-08-29 |
| AU9350898A (en) | 1999-04-12 |
| EE04494B1 (et) | 2005-06-15 |
| CN1271357A (zh) | 2000-10-25 |
| EE200000179A (et) | 2001-04-16 |
| PL339493A1 (en) | 2000-12-18 |
| HUP0003647A2 (hu) | 2001-08-28 |
| ID24373A (id) | 2000-07-13 |
| CN1143857C (zh) | 2004-03-31 |
| EA003084B1 (ru) | 2002-12-26 |
| HUP0003647A3 (en) | 2002-12-28 |
| IL134662A0 (en) | 2001-04-30 |
| AU735729B2 (en) | 2001-07-12 |
| JP2003525838A (ja) | 2003-09-02 |
| NO20001569D0 (no) | 2000-03-24 |
| NO20001569L (no) | 2000-03-24 |
| NZ503044A (en) | 2001-08-31 |
| KR20010015607A (ko) | 2001-02-26 |
| EP1017691A1 (en) | 2000-07-12 |
| CA2304849A1 (en) | 1999-04-01 |
| SK3902000A3 (en) | 2000-12-11 |
| WO1999015523A1 (en) | 1999-04-01 |
| EA200000352A1 (ru) | 2000-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9801599A2 (hu) | Alfa1L-agonista imidazolinszármazékok alkalmazása inkontinencia kezelésére szolgáló gyógyszerkészítmények előállítására, új imidazolin-származékok és eljárás ezek előállítására | |
| TR199701219T1 (xx) | Benzimidazol bile�ikleri, bu bile�ikleri i�eren ispen�iyar� bile�ikler. | |
| TR199901653T2 (xx) | Fitalazinonlar. | |
| TW328086B (en) | Biphenylamides, compositions comprising them and the preparation and use thereof | |
| NO994115L (no) | Nye 1,4-diazacykloheptanderivater og deres anvendelse i haaroksydasjonsfargestoffer | |
| TR200102403T2 (tr) | Piridopiranoazepin türevleri, bunların hazırlanmaları ve terapötik uygulamaları. | |
| ATE406346T1 (de) | Herstellung von n-substituierten 2,7-dialkyl-4- hydroxy-5-amino-8-aryl-octanoylamiden | |
| CO5150159A1 (es) | Derivados de 4-arilquinolin-2-ona 3-substituida como moduladores de los canales de potasio | |
| YU31699A (sh) | Hinolin i hinazolin jedinjenja korisna u terapiji,naročito u tretmanu benigne hiperplazije prostate | |
| HUP9903707A2 (hu) | 17Béta-karboxi-,-tio-karboxi-vagy -amido-androsztánszármazékok laktonszármazékai, előállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| HUP9901436A2 (hu) | N-(Amino-alkil)-fluorén-karboxamidok, mint dopamin receptor altípusú ligandumok | |
| FI961914A0 (fi) | Lyhytvaikutteiset dihydropyridiinit | |
| LU92263I2 (fr) | Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION) | |
| CO4970840A1 (es) | Ciertas 1-(2-naftil) y 1-(azanaftil)-4-(1-fenilmetil) pipe- razinas; ligandos especificos del subtipo receptor de la dopamina | |
| NO20022976D0 (no) | 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet | |
| FI964463A (fi) | Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina | |
| TR200000764T2 (tr) | Fosfolamban inhibitörleri olarak, 1-okza, aza ve tiyanaftalin-2-on'ların biseterleri. | |
| DE69319312D1 (de) | Photoreaktives Material | |
| GR3029471T3 (en) | 2-substituted quinolines for treating leishmanioses. | |
| HUP0001010A2 (hu) | Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| TR199902115T2 (xx) | 2,3- Dihidrofuro (3,2-b) piridiun t�revleri, haz�rlan��lar� ve terapide uygulanmalar�. | |
| HUP0001023A2 (hu) | 2-(Szubsztituált benzoil)-1-cikloalkánkarbonsav-származékok | |
| CO5040091A1 (es) | Derivados de urea | |
| TR200000057T2 (tr) | 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları. | |
| TR199801683A2 (xx) | Yeni �re t�revleri. |